An official website of the United States government
NIH Guide: Weekly Index for January 26, 2024
Weekly NIH Guide Notices
January 26, 2024
Policy Notices
General Notices
-
Notice of Intent to Publish a Multi-Agency initiative in support of Establishment of an Industry-University Cooperative Research Center (IUCRC) on Optical Imaging Phantom Development and Dissemination
(NOT-EB-24-004)National Institute of Biomedical Imaging and Bioengineering
-
NHLBI Announces Plan to Fund a Framingham Heart Study Exam for the Generation 2 and Omni 1 Cohorts
(NOT-HL-24-001)National Heart, Lung, and Blood Institute
-
Notice of NHLBI Participation in PAR-22-151 Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
(NOT-HL-24-073)National Heart, Lung, and Blood Institute
-
NIH Blueprint for Neuroscience Research: Request for Information (RFI) on the NIH Toolbox Assessments Conference
(NOT-AG-23-076)National Institute on AgingNational Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
Notice of Changes to Funding Opportunities
-
Notice of Need to Expire and Reissue NOT-AT-22-010 "Notice of Special Interest (NOSI): Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supplements)" to Change Due Dates
(NOT-AT-24-029)National Center for Complementary and Integrative Health
-
Notice of Need to Expire and Reissue NOT-AT-24-012 "Notice of Special Interest: National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program to Promote Diversity in Health Research" to Change Due Dates
(NOT-AT-24-031)National Center for Complementary and Integrative Health
-
Notice of Extension of the Expiration Date for PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)"
(NOT-CA-24-025)National Cancer Institute
-
Notice of Extension of the Expiration Date for PAR-21- 206 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)"
(NOT-CA-24-026)National Cancer Institute
-
Notice of NCIs Participation in PAR-23-319, Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional)
(NOT-CA-24-027)National Cancer Institute
-
Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
(NOT-FD-24-001)Food and Drug Administration
-
Notice of Change to Funding Opportunity: RFA-FD-24-025 Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
(NOT-FD-24-002)Food and Drug Administration
-
Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
(NOT-FD-24-003)Food and Drug Administration
-
Notice of Change to Receipt Dates for RFA-NS-24-013: Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
(NOT-NS-24-044)National Institute of Neurological Disorders and Stroke
-
Notice of Early Termination of PAR-24-078: Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
(NOT-OD-24-056)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Notices of Intent to Publish
-
Notice of Intent to Publish a Notice of Funding Opportunity for Diabetes Research Centers (P30 Clinical Trial Optional)
(NOT-DK-24-009)National Institute of Diabetes and Digestive and Kidney Diseases
Notices of Special Interest
-
Notice of Special Interest: Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supplements)
(NOT-AT-24-032)National Center for Complementary and Integrative Health
Funding Opportunities
-
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
(PAR-24-095)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
(PAR-24-096)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
(PAR-24-097)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
(PAR-24-098)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
(PAR-24-111)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): May 23, 2025
-
Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
(PAR-24-112)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): May 23, 2025
-
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
(PAR-24-113)John E. Fogarty International CenterNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Eye InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
(PAR-24-129)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsOffice of AIDS ResearchApplication Receipt Date(s): Not Applicable
-
Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)
(RFA-AI-24-003)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): May 31, 2024
-
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional
(RFA-FD-24-019)Food and Drug AdministrationApplication Receipt Date(s): March 25, 2024 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
-
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (UM1) Clinical Trials Not Allowed
(RFA-FD-24-021)Food and Drug AdministrationApplication Receipt Date(s): April 1, 2024
-
Development and Maintenance of Human and Animal Food Rapid Response Teams (U01) Clinical Trials Not Allowed
(RFA-FD-24-032)Food and Drug AdministrationApplication Receipt Date(s): April 1, 2024
-
Evaluation and Coordinating Center for the AHRQ/PCORI Learning Health System Embedded Scientist Training and Research Centers (U18)
(RFA-HS-24-002)Agency for Healthcare Research and QualityApplication Receipt Date(s): March 30, 2024
-
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
(RFA-NR-24-004)National Institute of Nursing ResearchNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionApplication Receipt Date(s): March 22, 2024
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster